Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues.
The Santa Clara, California-based medical devices company said its first-quarter profit, on an adjusted basis, rose to $1.37 per share from $1.21 per share in the year-ago period.
Unadjusted net income moved up to $352 million or $1.19 per share from $283 million or $0.93 per share in the corresponding quarter of 2019. At $1.76 billion, revenues were up 5% from last year.
Check this space to read management/analysts’ comments on quarterly reports
“The Agilent team delivered an excellent start to 2023 with broad-based growth across our end markets and geographic regions. These positive results reflect the resiliency and durability of our diversified business and put us in a solid position for the year ahead,” said Agilent’s CEO Mike McMullen.
Stocks you may like:
TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel
TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for
Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase
Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up
Infographic: Micron (MU) reports net loss for Q2; revenue down 53%
Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported